Evidence map›Paper›PMID 32514150›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2020

Uric acid and hypertension.

Miguel A Lanaspa, Ana Andres-Hernando, Masanari Kuwabara

Abstract readEditorial
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miguel A LanaspaDivision of Renal Diseases and Hypertension, School of Medicine, University of Colorado Denver, Denver, CO, USA.
Ana Andres-HernandoDivision of Renal Diseases and Hypertension, School of Medicine, University of Colorado Denver, Denver, CO, USA.
Masanari KuwabaraDivision of Renal Diseases and Hypertension, School of Medicine, University of Colorado Denver, Denver, CO, USA. kuwamasa728@gmail.com.

Funding

Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intoleranceR01DK108859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Miguel Angel Lanaspa Garcia · 2016 to 2026
$2.4M
A Novel Role for Vasopressin in Fructose-Induced Metabolic SyndromeR01DK121496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LANASPA GARCIA, MIGUEL ANGEL · 2020 to 2023
$1.6M
NIDDK NIH HHS R01 DK108859NIDDK NIH HHS R01 DK121496
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HumansHypertensionHyperuricemiaUric AcidUric AcidCausalityHypertensionMechanismRisk factorUric acid

Identifiers

PMID32514150
PMCPMC10000019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.